Evidence map›Paper›PMID 33284802›Full record

ArticlePLoS biology2020

Diagnosis of latent tuberculosis infection is associated with reduced HIV viral load and lower risk for opportunistic infections in people living with HIV.

Katharina Kusejko, Huldrych F Günthard, Gregory S Olson, Kyra Zens, Katharine Darling, Nina Khanna, Hansjakob Furrer, Pauline Vetter, Enos Bernasconi, Pietro Vernazza and 4 more

Open access · goldAbstract read
In one paragraph

Article in PLoS biology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed, 1 pooled it
0.5field-weighted citation impact, top 37% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 1 synthesis or guideline pooled it, 13 citations in OpenAlex.

  1. Pooled it
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. iScience · 2023
    Article
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 9 institutions in 1 country.

Katharina KusejkoDivision of Infectious Diseases and Hospital Epidemiology, University Hospital Zurich, Zurich, Switzerland.ORCID 0000-0002-4638-1940
Huldrych F GünthardDivision of Infectious Diseases and Hospital Epidemiology, University Hospital Zurich, Zurich, Switzerland.ORCID 0000-0002-1142-6723
Gregory S OlsonSeattle Children's Research Institute, Seattle, Washington, United States of America.ORCID 0000-0001-7181-9636
Kyra ZensInstitute of Experimental Immunology, University of Zurich, Zurich, Switzerland.
Katharine DarlingDepartment of Infectious Diseases, University Hospital Lausanne, Lausanne, Switzerland.
Nina KhannaInfectious Diseases and Hospital Epidemiology, University Hospital Basel, Basel, Switzerland.ORCID 0000-0002-2642-419X
Hansjakob FurrerDepartment of Infectious Diseases, Bern University Hospital, University of Bern, Bern, Switzerland.ORCID 0000-0002-1375-3146
Pauline VetterDivision of Infectious Diseases, Geneva University Hospitals, Geneva, Switzerland.
Enos BernasconiDivision of Infectious Diseases, Regional Hospital Lugano, Lugano, Switzerland.ORCID 0000-0002-9724-8373
Pietro VernazzaDivision of Infectious Diseases, Cantonal Hospital St Gallen, St. Gallen, Switzerland.
Matthias HoffmannDivision of Infectious Diseases, Cantonal Hospital Olten, Olten, Switzerland.
Roger D KouyosDivision of Infectious Diseases and Hospital Epidemiology, University Hospital Zurich, Zurich, Switzerland.ORCID 0000-0002-9220-8348
Johannes NemethDivision of Infectious Diseases and Hospital Epidemiology, University Hospital Zurich, Zurich, Switzerland.ORCID 0000-0003-0683-456X
Swiss HIV Cohort Study
University of Zurich · CHKantonsschule Olten · CHOspedale regionale di Lugano · CHUniversity Hospital of Basel · CHUniversity Hospital of Geneva · CHUniversity Hospital of Zurich · CHUniversity of Bern · CHUniversity of Lausanne · CHUniversity of St.Gallen · CH

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Approximately 28% of the human population have been exposed to Mycobacterium tuberculosis (MTB), with the overwhelming majority of infected individuals not developing disease (latent TB infection (LTBI)). While it is known that uncontrolled HIV infection is a major risk factor for the development of TB, the effect of underlying LTBI on HIV disease progression is less well characterized, in part because longitudinal data are lacking. We sorted all participants of the Swiss HIV Cohort Study (SHCS) with at least 1 documented MTB test into one of the 3 groups: MTB uninfected, LTBI, or active TB. To detect differences in the HIV set point viral load (SPVL), linear regression was used; the frequency of the most common opportunistic infections (OIs) in the SHCS between MTB uninfected patients, patients with LTBI, and patients with active TB were compared using logistic regression and time-to-event analyses. In adjusted models, we corrected for baseline demographic characteristics, i.e., HIV transmission risk group and gender, geographic region, year of HIV diagnosis, and CD4 nadir. A total of 13,943 SHCS patients had at least 1 MTB test documented, of whom 840 (6.0%) had LTBI and 770 (5.5%) developed active TB. Compared to MTB uninfected patients, LTBI was associated with a 0.24 decreased log HIV SPVL in the adjusted model (p < 0.0001). Patients with LTBI had lower odds of having candida stomatitis (adjusted odds ratio (OR) = 0.68, p = 0.0035) and oral hairy leukoplakia (adjusted OR = 0.67, p = 0.033) when compared to MTB uninfected patients. The association of LTBI with a reduced HIV set point virus load and fewer unrelated infections in HIV/TB coinfected patients suggests a more complex interaction between LTBI and HIV than previously assumed.

Indexed as

AdultAIDS-Related Opportunistic InfectionsCD4-Positive T-LymphocytesCohort StudiesDisease ProgressionFemaleHIV-1HIV InfectionsHumansInterferon-gammaLatent TuberculosisMaleMiddle AgedMycobacterium tuberculosisOpportunistic InfectionsRiskInterferon-gamma

Identifiers

PMID33284802
PMCPMC7721132
OpenAlexW3110998582

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.